Durabac Interactions
There are 587 drugs known to interact with Durabac (acetaminophen / caffeine / phenyltoloxamine / salicylamide), along with 22 disease interactions, and 5 alcohol/food interactions. Of the total drug interactions, 25 are major, 532 are moderate, and 30 are minor.
- View all 587 medications that may interact with Durabac
- View Durabac alcohol/food interactions (5)
- View Durabac disease interactions (22)
Most frequently checked interactions
View interaction reports for Durabac (acetaminophen / caffeine / phenyltoloxamine / salicylamide) and the medicines listed below.
- acetaminophen
- acetaminophen
- Actonel (risedronate)
- Actonel (risedronate)
- Adderall (amphetamine / dextroamphetamine)
- Adderall (amphetamine / dextroamphetamine)
- Arthrotec (diclofenac / misoprostol)
- Arthrotec (diclofenac / misoprostol)
- aspirin
- aspirin
- atenolol
- atenolol
- Atuss HX (guaifenesin / hydrocodone)
- Atuss HX (guaifenesin / hydrocodone)
- Avinza (morphine)
- Avinza (morphine)
- Benadryl Allergy (diphenhydramine)
- Benadryl Allergy (diphenhydramine)
- Calcium Oyster Shell (calcium carbonate)
- Calcium Oyster Shell (calcium carbonate)
- cefdinir
- cefdinir
- Celebrex (celecoxib)
- Celebrex (celecoxib)
- CellCept (mycophenolate mofetil)
- CellCept (mycophenolate mofetil)
- cimetidine
- cimetidine
- Cipro (ciprofloxacin)
- Cipro (ciprofloxacin)
Durabac alcohol/food interactions
There are 5 alcohol/food interactions with Durabac (acetaminophen / caffeine / phenyltoloxamine / salicylamide).
Durabac disease interactions
There are 22 disease interactions with Durabac (acetaminophen / caffeine / phenyltoloxamine / salicylamide) which include:
- alcoholism
- liver disease
- cardiac disease
- hypertension
- psychiatric disorders
- PUD
- GI toxicity
- Reye's syndrome
- PKU
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- cardiotoxicity
- liver disease
- renal dysfunction
- seizure disorders
- GERD
- anemia
- coagulation
- G-6-PD deficiency
- hepatotoxicity
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.